Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes
This study is ongoing, but not recruiting participants.
Study NCT00698789.   Last updated on December 4, 2008.
Information provided by Incyte Corporation
Please refer to this study by its ClinicalTrials.gov identifier: NCT00698789
Locations
United States, Arizona
Phoenix, Arizona, United States, 85029
Tucson, Arizona, United States, 85705
United States, California
Chula Vista, California, United States, 91911
Orange, California, United States, 92869
Mission Viejo, California, United States, 92691
San Diego, California, United States, 92117
Santa Ana, California, United States, 92701
Tustin, California, United States, 92780
Paramount, California, United States, 90723
Los Angeles, California, United States
United States, Colorado
Colorado Springs, Colorado, United States, 80909
United States, Florida
St. Petersburg, Florida, United States, 33709
United States, Kansas
Shawnee Mission, Kansas, United States, 66216
United States, Louisiana
Shreveport, Louisiana, United States, 71101
United States, Michigan
Dearborn, Michigan, United States, 48126
United States, Missouri
St. Louis, Missouri, United States, 63110
United States, Nebraska
Omaha, Nebraska, United States, 68154
United States, New Jersey
Elizabeth, New Jersey, United States, 07202
United States, North Carolina
Charlotte, North Carolina, United States, 28211
United States, Oklahoma
Oklahoma City, Oklahoma, United States, 73103
United States, Rhode Island
East Providence, Rhode Island, United States, 02914
United States, Texas
San Antonio, Texas, United States, 78229
Sponsors and Collaborators
Incyte Corporation